• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Hoffmann-La Roche

edit

Hoffmann-La Roche, Inc., also known as Roche, is a research-oriented pharmaceutical company. It provides medications in the areas of infectious diseases, metabolic diseases, neurology, oncology, transplantation and virology, AIDS, cardiovascular diseases, central nervous system disorders, and dermatology. Hoffmann-La Roche, Inc. was formerly known as Roche Chemical Works and changed its name to Hoffmann-La Roche Inc. in January 1929. The company was founded in 1905 and is headquartered in Nutley, New Jersey. It has research centers in Basel, Switzerland; Nutley, New Jersey; Penzberg, Germany; Shanghai, China; and Palo Alto, California. Hoffmann-La Roche, Inc. operates as a subsidiary of Roche Holding AG.

Recent Milestones

edit

• 
  Hoffmann-La Roche acquired Memory Pharmaceuticals for $62.9M. (11/25/08)
  Posted 9/9/09 at 6:14pm via rocheusa.com
• 
  Hoffmann-La Roche acquired Piramed for $175M. (4/15/08)
  Posted 9/21/09 at 5:51am via roche.com
• 
  Hoffmann-La Roche added L.Patrick Gage as Vice president. (1/1/89)
  Posted 4/17/13 at 1:18am
• 
  Hoffmann-La Roche added George B. Abercrombie as CEO.
  Posted 9/9/09 at 6:14pm
• 
  Hoffmann-La Roche added Christine Aylward as Director .
  Posted 5/1/11 at 9:41pm
• 
  Hoffmann-La Roche added William M. Burns as CEO.
  Posted 9/9/09 at 6:14pm

Videos

Screenshots

edit

Sources

1. Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals (rocheusa.com) [edit]
2. Roche fully acquires privately-owned biotech company Piramed (roche.com) [edit]